Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/09/646
Active ingredient: Talampanel
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Teva Pharma GmbH
Kandelstraße 10, 79199 Kirchzarten, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/06/2009 Orphan designation EMEA/OD/012/09 (2009)4684 of 12/06/2009
26/08/2010 Removal of orphan designation from Community Register